Loading...
A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
BACKGROUND: Diabetic nephropathy (DN) is a lethal diabetic microvascular complication characterized by chronic low-grade inflammation. The NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome is implicated in the progression of DN. MCC950 is a selective and potent inhibitor of NL...
Na minha lista:
| Udgivet i: | Diabetes Metab Syndr Obes |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6684489/ https://ncbi.nlm.nih.gov/pubmed/31447572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S199802 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|